Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

NASDAQ:CLMT - Nasdaq - US1314281049 - Common Stock - Currency: USD

13.98  -0.42 (-2.92%)

After market: 13 -0.98 (-7.01%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CLMT. CLMT was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. CLMT may be in some trouble as it scores bad on both profitability and health. CLMT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLMT has reported negative net income.
In the past year CLMT has reported a negative cash flow from operations.
CLMT had negative earnings in 4 of the past 5 years.
In multiple years CLMT reported negative operating cash flow during the last 5 years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of CLMT (-13.60%) is worse than 88.73% of its industry peers.
Industry RankSector Rank
ROA -13.6%
ROE N/A
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

In the last couple of years the Operating Margin of CLMT has declined.
The Gross Margin of CLMT (2.88%) is worse than 76.53% of its industry peers.
In the last couple of years the Gross Margin of CLMT has declined.
The Profit Margin and Operating Margin are not available for CLMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.88%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

1

2. Health

2.1 Basic Checks

CLMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLMT has been increased compared to 1 year ago.
The number of shares outstanding for CLMT has been increased compared to 5 years ago.
The debt/assets ratio for CLMT is higher compared to a year ago.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CLMT has an Altman-Z score of 1.10. This is a bad value and indicates that CLMT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.10, CLMT is in line with its industry, outperforming 46.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.1
ROIC/WACCN/A
WACC10.89%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.06 indicates that CLMT should not have too much problems paying its short term obligations.
CLMT's Current ratio of 1.06 is in line compared to the rest of the industry. CLMT outperforms 44.60% of its industry peers.
A Quick Ratio of 0.61 indicates that CLMT may have some problems paying its short term obligations.
CLMT has a Quick ratio of 0.61. This is in the lower half of the industry: CLMT underperforms 72.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.61
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

CLMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -6642.86%.
CLMT shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.90%.
Measured over the past years, CLMT shows a small growth in Revenue. The Revenue has been growing by 3.94% on average per year.
EPS 1Y (TTM)-6642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.84%
Revenue 1Y (TTM)24.9%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-1.18%

3.2 Future

The Earnings Per Share is expected to grow by 29.17% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.25% on average over the next years.
EPS Next Y51.25%
EPS Next 2Y41.81%
EPS Next 3Y28.93%
EPS Next 5Y29.17%
Revenue Next Year-9.62%
Revenue Next 2Y-3.55%
Revenue Next 3Y2.17%
Revenue Next 5Y7.25%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLMT. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 483.79, the valuation of CLMT can be described as expensive.
Based on the Price/Forward Earnings ratio, CLMT is valued a bit more expensive than the industry average as 70.42% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, CLMT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 483.79
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLMT indicates a slightly more expensive valuation: CLMT is more expensive than 74.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 79.1
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLMT does not grow enough to justify the current Price/Earnings ratio.
CLMT's earnings are expected to grow with 28.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.81%
EPS Next 3Y28.93%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLMT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALUMET INC

NASDAQ:CLMT (5/30/2025, 5:35:55 PM)

After market: 13 -0.98 (-7.01%)

13.98

-0.42 (-2.92%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners42.07%
Inst Owner Change6.39%
Ins Owners3.72%
Ins Owner Change1.95%
Market Cap1.21B
Analysts76.67
Price Target20.91 (49.57%)
Short Float %13.75%
Short Ratio7.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-158.08%
Min EPS beat(2)-346.52%
Max EPS beat(2)30.36%
EPS beat(4)2
Avg EPS beat(4)-89.27%
Min EPS beat(4)-346.52%
Max EPS beat(4)30.36%
EPS beat(8)4
Avg EPS beat(8)76.92%
EPS beat(12)5
Avg EPS beat(12)-483.8%
EPS beat(16)7
Avg EPS beat(16)-347.91%
Revenue beat(2)2
Avg Revenue beat(2)5.15%
Min Revenue beat(2)0.99%
Max Revenue beat(2)9.31%
Revenue beat(4)4
Avg Revenue beat(4)8.63%
Min Revenue beat(4)0.99%
Max Revenue beat(4)13.26%
Revenue beat(8)7
Avg Revenue beat(8)7.42%
Revenue beat(12)11
Avg Revenue beat(12)9.08%
Revenue beat(16)15
Avg Revenue beat(16)11.52%
PT rev (1m)-7.87%
PT rev (3m)-20.39%
EPS NQ rev (1m)3.97%
EPS NQ rev (3m)-186.97%
EPS NY rev (1m)-7.65%
EPS NY rev (3m)-3309.92%
Revenue NQ rev (1m)1.8%
Revenue NQ rev (3m)1.87%
Revenue NY rev (1m)-0.86%
Revenue NY rev (3m)-10.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 483.79
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 79.1
EPS(TTM)-4.72
EYN/A
EPS(NY)0.03
Fwd EY0.21%
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-0.73
OCFYN/A
SpS59.84
BVpS-9.95
TBVpS-9.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.88%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
F-Score3
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 47.76
Cap/Depr 49.87%
Cap/Sales 1.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.61
Altman-Z 1.1
F-Score3
WACC10.89%
ROIC/WACCN/A
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6642.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-407.84%
EPS Next Y51.25%
EPS Next 2Y41.81%
EPS Next 3Y28.93%
EPS Next 5Y29.17%
Revenue 1Y (TTM)24.9%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-1.18%
Revenue Next Year-9.62%
Revenue Next 2Y-3.55%
Revenue Next 3Y2.17%
Revenue Next 5Y7.25%
EBIT growth 1Y-138.21%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year3176.38%
EBIT Next 3Y277.46%
EBIT Next 5Y146.58%
FCF growth 1Y73.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-182.03%
OCF growth 3YN/A
OCF growth 5YN/A